European Patent Synthetic Phylomers

Bioshares Article

Shareholder Newsletter

Appendix 4C – Quarterly

Change of Director’s Interest Notice

Change in Substantial Holding

Change in Substantial Holding

Notice of Annual General Meeting/Proxy Form

Annual Report to Shareholders

Annual General Meeting Date

Investor Presentation

Grant for Cancer Drug Research

Appendix 4E and Audited Annual Financial Statements

Phylogica Patents Granted

Research Service Agreement with Genentech

Appendix 4C – Quarterly

Change in Substantial Holding

Becoming a Substantial Holder

Change in Substantial Holding

Appendix 4C – Quarterly

Half Yearly Report and Accounts

Half Yearly Report and Accounts

Investor Presentation

Response to ASX Price Query

Appendix 4C – Quarterly

Director Appointment

Initial Director’s Interest Notice

Change in Substantial Holding

Change of Director’s Interest Notice Hopkins

Change of Director’s Interest Notice McHarrie

Change of Director’s Interest Notice Wilson

Response to ASX Price and Volume Query

Entitlement Issue Result and Shortfall

Offer Document Despatch

Letter to Eligible Shareholders

Letter to Ineligible Shareholders

Letter to Eligible Shareholders

Letter to Ineligble Shareholders

Letter to Optionholders

Additional 708A Notice – Note Conversion

Entitlement Issue Offer Document

Entitlement Issue Application for Listing

Entitlement Issue S708AA Notice

Presentation to Shareholders

Results of Meeting

Rights Issue Update

Recapitalisation Update

Change of Director’s Interest Notice

Change in Substantial Holding

Section 708A Notice

Change in Substantial Holding

Application for Listing Employee Share Plan Allocation

Entitlement Issue and Note Conversion

Change in Substantial Holding

Appendix 4C – Quarterly

Annual Report to Shareholders

Investor Presentation

Notice of Annual General Meeting/Proxy Form

US Patent Synthetic Phylomer Libraries

Change of Director’s Interest Notice

Shareholder Newsletter

Appendix 4E and Audited Annual Financial Statements

Appendix 4C – Quarterly

Antimicrobial Phylomer Collaboration

Final Director’s Interest Notice

Initial Director’s Interest Notice

CEO and Director Changes

Grant Received for Phylomer Based Biosensor Device

Janssen Collaboration Expanded

New Patent to Discover Sophisticated Cell Penetrating Drugs

Change of Director’s Interest Notice

European Patent Granted

Appendix 4C – Quarterly

Phylogica Engages Financial Advisor

Phylogica Granted Core Phylomer® Patent In Australia

Core Patent Granted in Australia

Half Yearly Report and Accounts

Collaboration to Commercialise Anti Inflammatory Phylomers

Janssen Collaboration Extended

Appendix 4C – Quarterly

Appendix 3B Correction

Letter to Shareholders

Change of Director’s Interest Notice

Change of Director’s Interest Notice

Change of Director’s Interest Notice

Phylomer Library Upgrade

Annual General Meeting Presentation

Results of Meeting

Appendix 3B Unquoted ESOP Options